Browsing by Subject "Multi-target inhibitors"
Now showing items 1-1 of 1
-
MAO inhibitors and their wider applications: a patent review
(Taylor & Francis, 2018)Introduction: Monoamine oxidase (MAO) inhibitors, after the initial ‘golden age’, are currently used as third-line antidepressants (selective MAO-A inhibitors) or clinically enrolled as co-adjuvants for neurodegenerative ...